The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
To own Liquidia, you need to believe YUTREPIA can sustain meaningful use in pulmonary hypertension while the company manages payer dynamics and product concentration risk. The latest Q2 2026 results, with a rapid turn to profitability, strengthen the near term earnings story, but do not erase the key risk that reimbursement terms or uptake trends could blunt how much of this revenue surge translates into durable, repeatable earnings.
Among recent developments, Liquidia’s addition to the S&P Composite 1500 and related indices in June 2026 stands out. Index inclusion can deepen liquidity and broaden the shareholder base, which may matter as the company funds manufacturing expansion and advances L606. In the context of today’s earnings step up, this broader ownership could either support confidence in the growth path or magnify pressure if expectations around YUTREPIA or L606 begin to shift.
Yet against this strong profit swing, investors still need to watch how reliant Liquidia remains on YUTREPIA and what happens if...
Read the full narrative on Liquidia (it's free!)
Liquidia's narrative projects $1.4 billion revenue and $665.8 million earnings by 2029. This requires 68.6% yearly revenue growth and about a $643.5 million earnings increase from $22.3 million today.
Uncover how Liquidia's forecasts yield a $72.38 fair value, a 3% downside to its current price.
Some of the most optimistic analysts were already assuming Liquidia could reach about US$1.7 billion of revenue and US$917.0 million of earnings by 2029, so this profit jump may push them to revisit both the upside potential and the risk that ongoing patent disputes could still limit how much of that future actually reaches you as a shareholder.
Explore 5 other fair value estimates on Liquidia - why the stock might be worth 19% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com